SubstanceP(9-11) CAS PNA-1801
SubstanceP(9-11),PNA-1801,Gly-Leu-Met-NH2,C13H26N4O3S
Read moreProducts & Industries
SubstanceP-Gly-Lys-Arg CAS PNA-1802
SubstanceP-Gly-Lys-Arg,PNA-1802,Arg-Pro-Lys-Pro-Gln-Gln-Phe-
Read more
Phe-Gly-Leu-Met-Gly-Lys-Arg,C77H124N24O17SSuccinyl-(Glu9,Ala11,15)- Endothelin-1(8-21) CAS PNA-1807
Succinyl-(Glu9,Ala11,15)-
Read more
Endothelin-1(8-21),PNA-1807,Suc-Asp-Glu-Glu-Ala-Val-Tyr-
Phe-Ala-His-Leu-Asp-Ile-Ile-Trp,C86H118N17O27Somatostatin-14(3-10) CAS PNA-1768
Somatostatin-14(3-10),PNA-1768,Cys-Lys-Asn-Phe-Phe-Trp-Lys-
Read more
Thr,C52H72N12O11S
Somatostatin-14(3-14) CAS PNA-1769
Somatostatin-14(3-14),PNA-1769,Cys-Lys-Asn-Phe-Phe-Trp-Lys-
Read more
Thr-Phe-Thr-Ser-Cys
(Disulfidebridge:Cys1-Cys12),C71H96N16O17S2Somatostatin-14(7-14) CAS PNA-1770
Somatostatin-14(7-14),PNA-1770,Phe-Trp-Lys-Thr-Phe-Thr-Ser-
Read more
Cys,C49H66N10O12SSomatostatin-14(reduced) CAS PNA-1771
Somatostatin-14(reduced),PNA-1771,Ala-Gly-Cys-Lys-Asn-Phe-Phe-
Read more
Trp-Lys-Thr-Phe-Thr-Ser-Cys,C76H106N18O19S2Somatostatin-25 CAS PNA-1772
Somatostatin-25,PNA-1772,Ser-Asn-Pro-Ala-Met-Ala-Pro-Arg-
Read more
Glu-Arg-Lys-Ala-Gly-
Cys-Lys-Asn-Phe-Phe-Trp-Lys-
Thr-Phe-Thr-Ser-Cys
(Disulfidebridge:Cys14-Cys25),C127H191N37O34S3Somatostatin-28(1-12) CAS PNA-1773
Somatostatin-28(1-12),PNA-1773,Ser-Ala-Asn-Ser-Asn-Pro-Ala-
Read more
Met-Ala-Pro-Arg-Glu,C49H81N17O19SSomatostatin-28(1-14) CAS PNA-1774
Somatostatin-28(1-14),PNA-1774,Ser-Ala-Asn-Ser-Asn-Pro-Ala-
Read more
Met-Ala-Pro-Arg-Glu-Arg-
Lys,C61H105N23O21SSP1 CAS PNA-1775
SP1,PNA-1775,Gly-Phe-Arg-Leu-Thr-Asn-Phe-
Read more
Gly-Tyr-Phe-Glu-Pro-Gly,C72H97N17O19
New Products
- cefuroxime sodium Impurity F CAS 97170-19-9cefuroxime sodium Impurity F,97170-19-9,Cefuroxime Sodium […]
- Glycopeptidase ; PNGaseF CAS 83534-39-8 EC 3.5.1.52Glycopeptidase ; PNGaseF,83534-39-8,Glycopeptidase. Glycopeptide N-glycosidase. N-glycanase. N-oligosaccharide glycopeptidase.,3.5.1.52 […]
- 1,5,9-triazacyclododecane CAS 294-80-41,5,9-triazacyclododecane,294-80-4,,C9H21N3 […]
- meso-Tetra(4-methoxyphenyl)porphine CAS 22112-78-322112-78-3,meso-Tetra(4-methoxyphenyl)porphine,meso-Tetra(4-methoxyphenyl)porphine […]
- 3,4-Dihydroxybenzonitrile CAS 17345-61-83,4-Dihydroxybenzonitrile,17345-61-8,Protocatechuonitrile,C7H5NO2 […]
- Cyclopentaneheptanoic acid, 5-(acetyloxy)-2-(hydroxyMethyl)-3-[(tetrahydro-2H-pyran-2-yl)oxy]-, Methyl ester, (1R,2S,3R,5S)- CAS 61302-47-4Cyclopentaneheptanoic acid, 5-(acetyloxy)-2-(hydroxyMethyl)-3-[(tetrahydro-2H-pyran-2-yl)oxy]-, Methyl ester, (1R,2S,3R,5S)-,61302-47-4,PROMESTRIENE,Cyclopentaneheptanoic acid, 5-(acetyloxy)-2-(hydroxyMethyl)-3-[(tetrahydro-2H-pyran-2-yl)oxy]-, Methyl ester, (1R,2S,3R,5S)-;Methyl 7-((1R,2S,3R,5S)-5-acetoxy-2-(hydroxymethyl)-3-((tetrahydro-2H-pyran-2-yl)oxy)cyclopentyl);Cyclopentaneheptanoic acid, 5-(acetyloxy)-2-(hydroxyMethyl)-3-[(tetrahydro-2H-pyran-2-yl)oxy]-, Methyl ester, […]
- Ilunocitinib CAS 1187594-14-4Identification […]
- Trimethylolethane CAS 77-85-0Identification […]
- Fmoc-Pro-OH CAS 71989-31-6Fmoc-Pro-OH,71989-31-6,N-(9-Fluorenylmethoxycarbonyl)-L-proline ; Fmoc-Pro-OH,C20H19NO4 […]
- Fmoc-D-HomoArg(Pbf)-OH CAS 1313054-60-2Identification […]
![Structure of Cyclopentaneheptanoic acid, 5-(acetyloxy)-2-(hydroxyMethyl)-3-[(tetrahydro-2H-pyran-2-yl)oxy]-, Methyl ester, (1R,2S,3R,5S)- CAS 61302-47-4 61302-47-4](https://www.watson-int.com/wp-content/uploads/2016/07/Structure-of-Cyclopentaneheptanoic-acid-5-acetyloxy-2-hydroxyMethyl-3-tetrahydro-2H-pyran-2-yloxy-Methyl-ester-1R2S3R5S-CAS-61302-47-4-61302-47-4.jpg "Structure of Cyclopentaneheptanoic acid, 5-(acetyloxy)-2-(hydroxyMethyl)-3-[(tetrahydro-2H-pyran-2-yl)oxy]-, Methyl ester, (<span class=\"caps\">1R</span>,<span class=\"caps\">2S</span>,<span class=\"caps\">3R</span>,<span class=\"caps\">5S</span>)- <span class=\"caps\">CAS</span> 61302-47-4 61302-47-4")
© 2026 WATSON INTERNATIONAL LIMITED. All Rights Reserved. This site and all content are protected by international Copyright laws. Third party logos and marks appearing on this website are trademarks and/or registered trademarks of their respective owners and licensors, and all rights therein and thereto are reserved to such entities.